116 related articles for article (PubMed ID: 8483323)
61. Clinical and in vitro antiproliferative properties of recombinant DNA-derived human interferon-alpha 2.
Freedman MH; Estrov Z; Williams BR; Gelfand EW
Am J Pediatr Hematol Oncol; 1986; 8(3):178-82. PubMed ID: 3766908
[TBL] [Abstract][Full Text] [Related]
62. Cell growth-dependent changes in interferon-alpha receptor expression and induction of specific genes.
Williams BR; Hannigan GE; Saunders ME
Prog Clin Biol Res; 1985; 202():227-36. PubMed ID: 2938190
[No Abstract] [Full Text] [Related]
63. Heparanase expression in human leukemias is restricted to acute myeloid leukemias.
Bitan M; Polliack A; Zecchina G; Nagler A; Friedmann Y; Nadav L; Deutsch V; Pecker I; Eldor A; Vlodavsky I; Katz BZ
Exp Hematol; 2002 Jan; 30(1):34-41. PubMed ID: 11823035
[TBL] [Abstract][Full Text] [Related]
64. Absence of negative growth regulation in three new murine radiation-induced myeloid leukemia cell lines with deletion of chromosome 2.
Resnitzky P; Goren T; Shaft D; Trakhtenbrot L; Peled A; Resnitzky D; Zipori D; Haran-Ghera N
Leukemia; 1992 Dec; 6(12):1288-95. PubMed ID: 1453774
[TBL] [Abstract][Full Text] [Related]
65. The type I interferon system is locally activated in psoriatic lesions.
Schmid P; Itin P; Cox D; McMaster GK; Horisberger MA
J Interferon Res; 1994 Oct; 14(5):229-34. PubMed ID: 7861026
[TBL] [Abstract][Full Text] [Related]
66. Different antitumor mechanisms of interferon-alpha in the treatment of hairy cell leukemia and renal cell cancer.
Porzsolt F; Digel W; Jacobsen H; Mittnacht S; Kirchner H; Heimpel H
Cancer; 1988 Jan; 61(2):288-93. PubMed ID: 3334965
[TBL] [Abstract][Full Text] [Related]
67. Growth inhibitory effect of gene-cloned interferons on human myeloblast colonies.
Freedman MH; Fish E; Estrov Z; Grunberger T; Williams BR
Exp Hematol; 1985 Oct; 13(9):932-6. PubMed ID: 3862600
[TBL] [Abstract][Full Text] [Related]
68. Interferon-alpha alters spectrin organization in normal and leukemic human B lymphocytes.
Evans SS; Wang WC; Gregorio CC; Han T; Repasky EA
Blood; 1993 Feb; 81(3):759-66. PubMed ID: 8427967
[TBL] [Abstract][Full Text] [Related]
69. Interleukin-6 induces the (2'-5') oligoadenylate synthetase gene in M1 cells through an effect on the interferon-responsive enhancer.
Cohen B; Gothelf Y; Vaiman D; Chen L; Revel M; Chebath J
Cytokine; 1991 Mar; 3(2):83-91. PubMed ID: 1888886
[TBL] [Abstract][Full Text] [Related]
70. Reduction of N-myc expression by antisense RNA is amplified by interferon: possible involvement of the 2-5A system.
Schilbach K; Pollwein P; Schwab M; Handgretinger R; Treuner J; Niethammer D; Bruchelt G
Biochem Biophys Res Commun; 1990 Aug; 170(3):1242-8. PubMed ID: 1697169
[TBL] [Abstract][Full Text] [Related]
71. Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia.
Ganeshaguru K; de Mel WC; Sissolak G; Catovsky D; Dearden CE; Mehta AB; Hoffbrand AV
Adv Exp Med Biol; 1991; 309A():65-8. PubMed ID: 1789272
[No Abstract] [Full Text] [Related]
72. Physiological expression of the 2',5'-oligoadenylate synthetase gene in mouse intestine.
Sokawa Y; Kitano Y; Shimada M; Okumura M; Sokawa J; Ueda K; Hamada K; Takeda K
J Interferon Res; 1994 Jun; 14(3):121-7. PubMed ID: 7930758
[TBL] [Abstract][Full Text] [Related]
73. Regulation of c-myc expression by IFN in Burkitt's lymphoma cells.
Salehzada T; Blanchard JM; Mechti N; Piechaczyk M; Dani C; Jeanteur P; Lebleu B
Prog Clin Biol Res; 1985; 202():211-7. PubMed ID: 3832071
[No Abstract] [Full Text] [Related]
74. Study of the levels of expression of two oncogenes, c-myc and c-myb, in acute and chronic leukemias of both lymphoid and myeloid lineage.
Ferrari S; Torelli U; Selleri L; Donelli A; Venturelli D; Narni F; Moretti L; Torelli G
Leuk Res; 1985; 9(7):833-42. PubMed ID: 3860696
[TBL] [Abstract][Full Text] [Related]
75. Existence of tartrate-resistant acid phosphatase activity in differentiated lymphoid leukemic cells.
Usui T; Konishi H; Sawada H; Uchino H
Am J Hematol; 1982 Feb; 12(1):47-54. PubMed ID: 6801973
[TBL] [Abstract][Full Text] [Related]
76. [Association of polymorphism of 2'-5' oligoadenylate synthetase 1 gene with the susceptibility of hepatitis B virus infection and IFN-alpha treatment response].
Sun XF; Zhang XX; Yang ZT; Xu J; Huang L; Gong QM; Jin GD; Jiang JH; Gao J; Lu M; Lu ZM
Zhonghua Gan Zang Bing Za Zhi; 2007 Oct; 15(10):779-80. PubMed ID: 17963609
[No Abstract] [Full Text] [Related]
77. Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences.
Benech P; Mory Y; Revel M; Chebath J
EMBO J; 1985 Sep; 4(9):2249-56. PubMed ID: 2416561
[TBL] [Abstract][Full Text] [Related]
78. Expression of IFN-Inducible Genes with Antiviral Function OAS1 and MX1 in Health and under Conditions of Recurrent Herpes Simplex Infection.
Karaulov AV; Shulzhenko AE; Karsonova AV
Bull Exp Biol Med; 2017 Jul; 163(3):370-373. PubMed ID: 28744639
[TBL] [Abstract][Full Text] [Related]
79. mRNA levels and methylation patterns of the 2-5A synthetase gene in control and Alzheimer's disease (AD) fibroblasts.
An S; Khanna KK; Wu JM
Biochem Mol Biol Int; 1994 Aug; 33(5):835-40. PubMed ID: 7527263
[TBL] [Abstract][Full Text] [Related]
80. Relationship of the clinical response and binding of recombinant interferon alpha in patients with lymphoproliferative diseases.
Faltynek CR; Princler GL; Rossio JL; Ruscetti FW; Maluish AE; Abrams PG; Foon KA
Blood; 1986 Apr; 67(4):1077-82. PubMed ID: 2937469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
